Format
Items per page
Sort by

Send to:

Choose Destination

Results: 9

Cited In for PubMed (Select 119267)

1.

Anticonvulsant drugs in bipolar disorder.

Grunze H, Schlösser S, Amann B, Walden J.

Dialogues Clin Neurosci. 1999 Jun;1(1):24-40.

2.

Review of pharmacological treatment in mood disorders and future directions for drug development.

Li X, Frye MA, Shelton RC.

Neuropsychopharmacology. 2012 Jan;37(1):77-101. doi: 10.1038/npp.2011.198. Epub 2011 Sep 7. Review.

3.

Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis.

Tamayo JM, Zarate CA Jr, Vieta E, Vázquez G, Tohen M.

Int J Neuropsychopharmacol. 2010 Jul;13(6):813-32. doi: 10.1017/S1461145709991246. Epub 2010 Feb 4. Review.

4.
5.
6.

Therapeutic drug monitoring of psychotropic medications.

Mitchell PB.

Br J Clin Pharmacol. 2000 Apr;49(4):303-12. Review.

7.

The manic syndrome: factors which may predict a patient's response to lithium, carbamazepine and valproate.

Dilsaver SC, Swann AC, Shoaib AM, Bowers TC.

J Psychiatry Neurosci. 1993 Mar;18(2):61-6. Review.

8.

Carbamazepine and psychotherapy in the treatment of schizoaffective psychosis.

Cegalis JA, Possick SG.

Yale J Biol Med. 1985 Jul-Aug;58(4):327-36.

9.

The use of carbamazepine in the treatment of schizophrenic and schizoaffective psychoses: a review.

Simhandl C, Meszaros K.

J Psychiatry Neurosci. 1992 Mar;17(1):1-14. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk